Genmab A/S - Common Stock - Foreign

Historical Holders from Q1 2020 to Q3 2025

Type / Class
Equity / Common Stock - Foreign
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,793
Holdings value
$6,909,903
% of all portfolios
0%
Number of holders
1
Number of buys
1
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Genmab A/S - Common Stock - Foreign

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 22,793 $6,909,903 +$304,675 $303.16 1
2025 Q2 21,788 $4,523,579 +$774,000 $207.62 1
2025 Q1 18,060 $3,507,482 -$937,754 $194.21 1
2024 Q4 22,712 $4,708,350 +$4,705,862 $207.28 2
2024 Q3 12 $2,903 +$968 $241.92 1
2024 Q2 8 $2,005 $250.62 1
2024 Q1 8 $2,411 +$2,411 $301.38 1
2023 Q4 0 $0 -$24,926 0
2023 Q3 70 $24,926 +$24,926 $356.09 1
2021 Q1 0 $0 -$1,238,889 0
2020 Q4 3,060 $1,238,889 $404.87 1
2020 Q3 3,060 $1,108,739 +$39,857 $362.33 1
2020 Q2 2,950 $986,897 $334.54 1
2020 Q1 2,950 $597,305 +$597,305 $202.48 1